Jaguar Health Granted Extension and Announces Reverse Stock Split

Jaguar Health, Inc. has received an extension from the Nasdaq Hearings Panel to comply with the $1.00 bid price rule by May 15, 2026. The company must sustain a closing bid price of at least $1.00 per share for ten consecutive business days within this timeframe. To assist with compliance, Jaguar will enact a reverse stock split at a 1-for-35 ratio on April 30, 2026. Post-split, the shares will trade adjusted under the symbol "JAGX."

The reverse split follows stockholder approval at a special meeting, with further details available in the SEC proxy statement. On the effective date, every 35 shares will reclassify into one, without altering the par value. Equiniti Trust Company manages the exchange process for stockholders.